Barclays Initiates Coverage On Sutro Biopharma with Overweight Rating, Announces Price Target of $56
Sutro Biopharma Inc STRO
$29.24
▼ -1.32%
($-0.39)
Open
$29.63
Prev Close
$29.63
Day Range
$28.41 – $29.67
52W Range
$6.74 – $43.85
Market Cap
$484.35M
Beta
1.54
EPS (TTM)
$-16.35
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-09-27 |
| Shares Out. | 16,570,000 |
| Website | sutrobio.com/ ↗ |
| Phone | 13026587581 |
Sutro Biopharma Inc is a publicly traded company under the ticker symbol STRO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)